These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 27537937)
1. Protein phosphatase PP2A - a novel interacting partner of carnitine transporter OCTN2 (SLC22A5) in rat astrocytes. Juraszek B; Nałęcz KA J Neurochem; 2016 Nov; 139(4):537-551. PubMed ID: 27537937 [TBL] [Abstract][Full Text] [Related]
2. Caveolin-1--a novel interacting partner of organic cation/carnitine transporter (Octn2): effect of protein kinase C on this interaction in rat astrocytes. Czeredys M; Samluk Ł; Michalec K; Tułodziecka K; Skowronek K; Nałęcz KA PLoS One; 2013; 8(12):e82105. PubMed ID: 24349196 [TBL] [Abstract][Full Text] [Related]
3. Tight junction protein ZO-1 controls organic cation/carnitine transporter OCTN2 (SLC22A5) in a protein kinase C-dependent way. Jurkiewicz D; Michalec K; Skowronek K; Nałęcz KA Biochim Biophys Acta Mol Cell Res; 2017 May; 1864(5):797-805. PubMed ID: 28257821 [TBL] [Abstract][Full Text] [Related]
4. Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood-brain barrier. Miecz D; Januszewicz E; Czeredys M; Hinton BT; Berezowski V; Cecchelli R; Nałecz KA J Neurochem; 2008 Jan; 104(1):113-23. PubMed ID: 17995936 [TBL] [Abstract][Full Text] [Related]
5. The activity and surface presence of organic cation/carnitine transporter OCTN2 (SLC22A5) in breast cancer cells depends on AKT kinase. Papierniak-Wyglądała A; Lamch W; Jurewicz E; Nałęcz KA Arch Biochem Biophys; 2023 Jul; 742():109616. PubMed ID: 37187422 [TBL] [Abstract][Full Text] [Related]
6. Regulation of Octn2 transporter (SLC22A5) by peroxisome proliferator activated receptor alpha. Maeda T; Wakasawa T; Funabashi M; Fukushi A; Fujita M; Motojima K; Tamai I Biol Pharm Bull; 2008 Jun; 31(6):1230-6. PubMed ID: 18520060 [TBL] [Abstract][Full Text] [Related]
7. SLC22A5 (OCTN2) Carnitine Transporter-Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer. Juraszek B; Nałęcz KA Molecules; 2019 Dec; 25(1):. PubMed ID: 31861504 [TBL] [Abstract][Full Text] [Related]
8. Organic cation/carnitine transporter OCTN3 is present in astrocytes and is up-regulated by peroxisome proliferators-activator receptor agonist. Januszewicz E; Pajak B; Gajkowska B; Samluk L; Djavadian RL; Hinton BT; Nałecz KA Int J Biochem Cell Biol; 2009 Dec; 41(12):2599-609. PubMed ID: 19735737 [TBL] [Abstract][Full Text] [Related]
9. Protein kinase C restricts transport of carnitine by amino acid transporter ATB(0,+) apically localized in the blood-brain barrier. Michalec K; Mysiorek C; Kuntz M; Bérézowski V; Szczepankiewicz AA; Wilczyński GM; Cecchelli R; Nałęcz KA Arch Biochem Biophys; 2014 Jul; 554():28-35. PubMed ID: 24823859 [TBL] [Abstract][Full Text] [Related]
10. Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes. Inazu M; Takeda H; Maehara K; Miyashita K; Tomoda A; Matsumiya T J Neurochem; 2006 Apr; 97(2):424-34. PubMed ID: 16539668 [TBL] [Abstract][Full Text] [Related]
11. Muscle contraction increases carnitine uptake via translocation of OCTN2. Furuichi Y; Sugiura T; Kato Y; Takakura H; Hanai Y; Hashimoto T; Masuda K Biochem Biophys Res Commun; 2012 Feb; 418(4):774-9. PubMed ID: 22310714 [TBL] [Abstract][Full Text] [Related]
12. Carnitine transport and fatty acid oxidation. Longo N; Frigeni M; Pasquali M Biochim Biophys Acta; 2016 Oct; 1863(10):2422-35. PubMed ID: 26828774 [TBL] [Abstract][Full Text] [Related]
13. Species specificity profiling of rat and human organic cation/carnitine transporter Slc22a5/SLC22A5 (Octn2/OCTN2). Szabó K; Nagy Z; Juhász V; Zolnerciks JK; Csorba A; Tímár Z; Molnár É; Pádár P; Johnson W; Beéry E; Krajcsi P Drug Metab Pharmacokinet; 2017 Jun; 32(3):165-171. PubMed ID: 28365301 [TBL] [Abstract][Full Text] [Related]
14. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse. Kato Y; Sugiura M; Sugiura T; Wakayama T; Kubo Y; Kobayashi D; Sai Y; Tamai I; Iseki S; Tsuji A Mol Pharmacol; 2006 Sep; 70(3):829-37. PubMed ID: 16754783 [TBL] [Abstract][Full Text] [Related]
15. Hepatic uptake of gamma-butyrobetaine, a precursor of carnitine biosynthesis, in rats. Fujita M; Nakanishi T; Shibue Y; Kobayashi D; Moseley RH; Shirasaka Y; Tamai I Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G681-6. PubMed ID: 19679820 [TBL] [Abstract][Full Text] [Related]
16. Glycosylation of the OCTN2 carnitine transporter: study of natural mutations identified in patients with primary carnitine deficiency. Filippo CA; Ardon O; Longo N Biochim Biophys Acta; 2011 Mar; 1812(3):312-20. PubMed ID: 21126579 [TBL] [Abstract][Full Text] [Related]
17. Functional expression of organic cation/carnitine transporter 2 (OCTN2/SLC22A5) in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model. Okura T; Kato S; Deguchi Y Drug Metab Pharmacokinet; 2014; 29(1):69-74. PubMed ID: 23877104 [TBL] [Abstract][Full Text] [Related]
18. Colistin is substrate of the carnitine/organic cation transporter 2 (OCTN2, SLC22A5). Visentin M; Gai Z; Torozi A; Hiller C; Kullak-Ublick GA Drug Metab Dispos; 2017 Dec; 45(12):1240-1244. PubMed ID: 28986476 [TBL] [Abstract][Full Text] [Related]
19. Functional regions of organic cation/carnitine transporter OCTN2 (SLC22A5): roles in carnitine recognition. Inano A; Sai Y; Kato Y; Tamai I; Ishiguro M; Tsuji A Drug Metab Pharmacokinet; 2004 Jun; 19(3):180-9. PubMed ID: 15499185 [TBL] [Abstract][Full Text] [Related]
20. Recent advances in drug delivery via the organic cation/carnitine transporter 2 (OCTN2/SLC22A5). Kou L; Sun R; Ganapathy V; Yao Q; Chen R Expert Opin Ther Targets; 2018 Aug; 22(8):715-726. PubMed ID: 30016594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]